CAS: 94695-50-8; Ethyl 3-Oxo-3-(2,3,4,5-Tetrafluorophenyl)Propanoate

该化合物是一种氟化有机化合物,其特征是附于苯环的多种氟原子,这对其化学特性有重大影响.该 ----异丙苯结构的存在表明,它含有一个与芳香系统相邻的碳基组,有助于其在有机合成中产生反应和潜在应用.乙酯功能组表示,它可以进行水解以形成相应的酸,使其在各种化学反应中具有多种特性.氟化物的子组增强化合物的脂性与热稳定性,这在制药和农用化学应用中可能具有优势.此外,功能组的独特组合可能带来具体的生物活动,使其成为医药化学的一个主题.

结构式图片

欧盟法规

REACH注册ECHA物质

上下游产品

CAS号6148-64-7 丙二酸单乙酯钾盐 | CAS号94695-48-4 2,3,4,5-四氟苯甲酰氯 | CAS号1071-46-1 丙二酸单乙酯 | CAS号94695-52-0 1-环丙基-6,7,8-三氟-... | CAS号79660-46-1 6,7,8-三氟-1,4-二氢... | CAS号82419-35-0 氟嗪羧酸 | CAS号100986-85-4 左氧氟沙星 | CAS号100986-86-5 R-9-氟-2,3-二氢-3-... | CAS号100986-89-8 左旋氧氟沙星羧酸 | CAS号115841-55-9 2,3-Dehydro Ofl... | CAS号113211-53-3 9'-fluoro-10'-(... | CAS号94242-51-0 莫西沙星三氟乙酯 | CAS号99734-97-1 1-Cyclopropyl-7...

合成工艺路线路线简述

  • 1201-31-6 + 105-53-3 = 94695-50-8
    反应条件:1.1 Reagents: Thionyl Chloride; 3 H,Reflux1.2 Reagents: Magnesium Solvents: Carbon Tetrachloride,Ethanol,Toluene; Rt -> Reflux; 1 H,Reflux; 1.5 H,60 °C; 60 °C -> 5 °C1.3 Solvents: Toluene; 40 Min,0 - 5 °C; 1 H,0 °C1.4 Reagents: Hydrochloric Acid Solvents: Water1.5 Catalysts: P-Toluenesulfonic Acid Solvents: Water; 4 H,Reflux; Reflux -> Rt
    标题:Synthesis,Structure And Antibacterial Activity Of 4,4'-(Methylene)Bis[1,2-Dihydro-2-Phenyl-53-(2,3,4,5-Tetrafluorophenyl)-3-Pyrazolone]
    作者:Zhang,Ji-Yun; Liu,Nian-Li; Wang,Zhi-Feng; Yu,Fei; Tian,Lai-Jin
    参考文献:Qufu Shifan Daxue Xuebao 日期:2010 卷标:36(3) 页码:83-87]

    6148-64-7 + 94695-48-4 = 94695-50-8
    反应条件:1.1 Reagents: Triethylamine,Magnesium Chloride Solvents: Dichloromethane; 0.5 H,0 °C; 15 H,0 °C -> 20 °C
    标题:Process For Preparation Of Ethyl 2-(2,3,4,5-Tetrafluorobenzoyl)Acetate
    参考文献:China]

    94695-49-5 = 94695-50-8
    反应条件:1.1 Catalysts: P-Toluenesulfonic Acid Solvents: Water; 5 H,Reflux
    标题:Preparation Of Uracils And Related Compounds As Antibacterials That Inhibit Bacterial Dna Polymerase Iiic And Type Ii Bacterial Topoisomerase.
    参考文献:United States]

    6148-64-7 + 94695-48-4 = 94695-50-8
    反应条件:1.1 Reagents: Triethylamine,Magnesium Chloride Solvents: Acetonitrile; 2.5 H,10 - 15 °C1.2 Solvents: Acetonitrile; 15 Min,0 °C; 0 °C -> Rt; 16 H,Rt1.3 Reagents: Hydrochloric Acid Solvents: Toluene,Water; < 25 °C
    标题:Preparation Of Fused Pyridone Hydrazides As Anticancer Drugs.
    参考文献:World Intellectual Property Organization]

    6148-64-7 + 94695-48-4 = 94695-50-8
    反应条件:1.1 Reagents: Triethylamine,Magnesium Chloride Solvents: Acetonitrile; 2.5 H,10 - 15 °C1.2 Reagents: Triethylamine Solvents: Acetonitrile; 15 Min,0 °C; 0 °C; 0 °C -> Rt; 16 H,Rt1.3 Reagents: Hydrochloric Acid Solvents: Toluene,Water; < 25 °C
    标题:Preparation Of Substituted Quinobenzoxazine Analogs As Antitumor Agents
    参考文献:United States]

    6148-64-7 + 94695-48-4 = 94695-50-8
    反应条件:1.1 Reagents: Triethylamine,Magnesium Chloride Solvents: Ethyl Acetate
    标题:Synthesis Of Ethyl (2,3,4,5-Tetrafluorobenzoyl)Acetate
    作者:Wang,Bin; Liang,Yanyu; Wang,Xunqiu
    参考文献:Huaxue Shiji 日期:2001 卷标:23(6) 页码:372-373]

    1071-46-1 + 94695-48-4 = 94695-50-8
    反应条件:1.1 Reagents: Butyllithium Solvents: Tetrahydrofuran1.2 -
    标题:1-Substituted 7-[3-[(Ethylamino)Methyl]-1-Pyrrolidinyl]-6,8-Difluoro-1,4-Dihydro-4-Oxo-3-Quinolinecarboxylic Acids. New Quantitative Structure Activity Relationships At N1 For The Quinolone Antibacterials
    作者:Domagala,John M.; Heifetz,Carl L.; Hutt,Marland P.; Mich,Thomas F.; Nichols,Jeffry B.; Et Al
    参考文献:Journal Of Medicinal Chemistry 日期:1988 卷标:31(5) 页码:991-1001]

    94695-49-5 = 94695-50-8
    反应条件:1.1 Reagents: Water; 10 H,150 °C
    标题:Improved Method For Preparation Of 2,3,4,5-Tetrafluorobenzoylacetic Acid Ethyl Ester
    参考文献:China
Diethyl (2,3,4,5-Tetrafluorobenzoyl)Malonate置于对甲苯磺酸体系中,用 水 作为反应溶剂,化学反应生成 左氧氟单酯
参考文献:Antibacterial 1,7-Diamino-1,4-Dihydro-4-Oxo-3-Quinolinecarboxylic Acids
标题:Antibacterial 1,7-Diamino-1,4-Dihydro-4-Oxo-3-Quinolinecarboxylic Acids
摘要:公式为 ##str1## 的抗菌有效的1,7-二氨基-1,4-二氢-4-氧基-3-(氮)喹啉羧酸,其中a是氮或c--R.Sup.1,R.Sup.1是硝基或卤素,R.Sup.2和r.Sup.3各自独立地是c.Sub.1-C.Sub.3-烷基,或者与它们所结合的氮原子一起形成一个5-或6-成员的杂环环,该环还可以包含原子或基团--O--,--S--,--So--,--So.Sub.2--或.Dbd.N--R.Sup.4作为环成员,并且可以在碳原子上选择性地被c.Sub.1-C.Sub.3-烷基,羟基,具有1-3个碳原子的烷氧基,氨基,甲氨基或乙氨基单独或二重取代,R.Sup.4是氢,具有1到4个碳原子并且可以被具有1到3个碳原子的烷基基团的羟基,烷氧基,烷基硫醇,烷基氨基或二烷基氨基基团取代的烷基或烯基基团,氰基或醇部分具有1到4个碳原子的烷氧羰基基团,苄氧羰基基团,具有最多4个碳原子的脂肪部分并且在苯基基团中可以选择性地被羟基,甲氧基,氯或氟单独或双重取代的苯基烷基基团,可以选择性地被羟基,甲氧基,氯或氟单独或双重取代的苯基乙酰基基团,具有最多6个碳原子的氧代烷基基团或具有最多6个碳原子的环烷基-烷基基团,其中环烷基部分具有最多6个碳原子,非环烷基部分具有最多3个碳原子,R.Sup.5和r.Sup.6各自独立地是氢或具有1到4个碳原子的烷基基团,X是氢,硝基或卤素,或其药学上可接受的盐.

海关参考信息

专利信息


专利号:US-6528517-B1
优先权日:1998-02-04
标题:Synthesis of quinobenzoxazine analogues with topoisomerase II and quadruplex interactions for use as antineoplastic agents
发明人:HURLEY LAURENCE H; ZENG QINGPING; KWOK YAN; GAM JONGSIK; KERWIN SEAN M
权利人:UNIV TEXAS
摘要:The present invention discloses a novel quinobenzoxazine self-assembly complex on DNA and on the topoisomerase II-DNA complex. The related model is used to design a new series of quinobenzoxazines, pyridobenzophenoxazines, pyrridonaphthophenoxazines, and other related compounds that may exhibit anticancer or antibiotic activity. The anticancer activity of these compounds is thought to operate via stabilization of the topoisomerase II-DNA complex and/or interaction with G-quadruplexes, while the antibiotic activity of these compounds derives from their ability to inhibit gyrase, the bacterial type II topoisomerase.

专利号:WO-9940093-A2
优先权日:1998-02-04
标题 :Synthesis of quinobenzoxazine analogues with topoisomerase ii and quadruplex interactions for use as antineoplastic agents

专利号:EP-1401829-B1
优先权日:2001-06-15
标题 :Novel heterocyclic antibacterial compounds
发明人:ZHI CHENGXIN; WRIGHT GEORGE E
权利人:MICROBIOTIX INC
摘要:The invention provides heterocyclic organic compounds that inhibit bacterial DNA polymerase IIIC and type II bacterial topoisomerase. The invention further provides compounds that are useful as intermediates in the synthesis of such heterocyclic organic compounds. Syntheses and uses of such heterocyclic organic molecules are also described.

专利号:US-6777420-B2
优先权日:2001-06-15
标题 :Heterocyclic antibacterial compounds
发明人:ZHI CHENGXIN; WRIGHT GEORGE E
权利人:MICROBIOTIX INC
摘要:The invention provides heterocyclic organic compounds that inhibit bacterial DNA polymerase IIIC and type II bacterial topoisomerase. The invention further provides compounds that are useful as intermediates in the synthesis of such heterocyclic organic compounds. Syntheses and uses of such heterocyclic organic molecules are also described.

专利号:US-2009012071-A1
优先权日:2007-04-23
标 题 :4-substituted-1h-isothiazolo[5,4-b][1,4]oxazino[2,3,4-ij]quinoline-7,8(2h,9h)-diones and related compounds as anti-infective agents
发明人:BRADBURY BARTON JAMES; DESHPANDE MILIND; HASHIMOTO AKIHIRO; KIM HA YOUNG; LUCIEN EDLAINE; PAIS GODWIN; PUCCI MICHAEL JOHN; WANG QIUPING; WILES JASON ALLAN
权利人:ACHILLION PHARMACEUTICALS INC
摘要:The present invention provides compounds of the formula that possess antimicrobial activity. Certain compounds provided herein possess potent antibacterial, antiprotozoal, or antifungal activity. Particular compounds provided herein are also potent and/or selective inhibitors of microbial DNA synthesis and reproduction. The invention provides anti-microbial compositions, including pharmaceutical compositions, containing a compound of the invention and one or more or more carriers. The invention provides pharmaceutical compositions containing a 4-substituted- 1 H-isothiazolo[5,4-b][1,4]oxazino[2,3,4-ij]quinoline-7,8(2H,9H)-dione or related compound as the only active agent or in combination with one or more other active agents. The invention provides methods for treating or preventing microbial infections, preferably animals, by administering an effective amount of a 4-substituted- 1 H-isothiazolo[5,4-b][1,4]oxazino[2,3,4-ij]quinoline-7,8(2H,9H)-dione or related compound to an organism suffering from or susceptible to microbial infection. The invention also provides methods of inhibiting microbial growth and survival by applying an effective amount of a 4-substituted- 1 H-isothiazolo[5,4-b][1,4]oxazino[2,3,4-ij]quinoline-7,8(2H,9H)-dione or related compound.
上海威远精细氟科技发展有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.shwychem.com
企业联系电话:021-64251386 64253204👤
📞上海威远精细氟科技发展有限公司 ⚠️参考联系方式

电话:021-64251386 64253204

传真:021-64253354
邮箱:wdchen@shwychem.com
通信地址: 上海梅陇路130号华东理工科技大楼
邮编: 200237
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:上海梅陇路130号华东理工科技大楼
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
浙江新昌浙邦化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.zbpharm.com
电话: 0575-82732308👤
📞浙江新昌浙邦化工有限公司 ⚠️参考联系方式

销售电话:0575-82732308
邮箱:info@zbpharm.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
嘉兴天源药业有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.ty-pharma.com
电话: 0573-86510965👤
📞嘉兴天源药业有限公司 ⚠️参考联系方式

销售电话:0573-86510965
邮箱:hy-tianyuan@21cn.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:Zhdankin, V. V., Science of Synthesis Knowledge Updates, (2015) 1, 265.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知